or Try an Advanced Search...

    Technical Analysis for ANTX - AN2 Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 1.45 11.15% 0.15
    ANTX closed up 22.64 percent on Wednesday, November 20, 2024, on 13.07 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical ANTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 11.15%
    MACD Bullish Centerline Cross Bullish 11.15%
    MACD Bullish Signal Line Cross Bullish 11.15%
    Expansion Breakout Bullish Swing Setup 11.15%
    Expansion Pivot Buy Setup Bullish Swing Setup 11.15%
    Pocket Pivot Bullish Swing Setup 11.15%
    Volume Surge Other 11.15%
    Wide Range Bar Range Expansion 11.15%
    Above Upper BB Strength 11.15%
    Upper Bollinger Band Touch Strength 11.15%
    Older End-of-Day Signals for ANTX ...

       Recent Intraday Alerts

    Alert Time
    Expansion Pivot Buy Entry about 1 hour ago
    Rose Above Previous Day's High about 1 hour ago
    2x Volume Pace about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    3x Volume Pace about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ANTX Chart by TradingView
    Basic chart:

    Profile

    AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases

    Is ANTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 AN2 Therapeutics GAAP EPS of -$0.43
    Nov 14 AN2 Therapeutics to Participate at Upcoming Investor Conferences
    Nov 13 AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline
    Oct 3 Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
    Aug 28 AN2 Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 19 AN2 Therapeutics (ANTX) Plunges 66% in a Month: Here's Why
    Aug 16 AN2 Therapeutics Adopts Limited Duration Stockholder Rights Plan
    Aug 14 AN2 Therapeutics GAAP EPS of -$0.48
    Aug 13 AN2 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business and Scientific Highlights
    Aug 9 Top Midday Decliners
    See more ANTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.15
    52 Week Low 0.87
    Average Volume 424,853
    200-Day Moving Average 2.34
    50-Day Moving Average 1.06
    20-Day Moving Average 1.08
    10-Day Moving Average 1.07
    Average True Range 0.06
    RSI (14) 75.90
    ADX 24.39
    +DI 41.78
    -DI 13.37
    Chandelier Exit (Long, 3 ATRs) 1.15
    Chandelier Exit (Short, 3 ATRs) 1.16
    Upper Bollinger Bands 1.20
    Lower Bollinger Band 0.96
    Percent B (%b) 1.39
    BandWidth 22.88
    MACD Line 0.01
    MACD Signal Line -0.01
    MACD Histogram 0.0132
    Fundamentals Value
    Market Cap 38.66 Million
    Num Shares 29.7 Million
    EPS -2.80
    Price-to-Earnings (P/E) Ratio -0.46
    Price-to-Sales 0.00
    Price-to-Book 4.28
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.69
    Resistance 3 (R3) 1.66 1.49 1.63
    Resistance 2 (R2) 1.49 1.39 1.51 1.60
    Resistance 1 (R1) 1.40 1.33 1.45 1.43 1.58
    Pivot Point 1.23 1.23 1.26 1.25 1.23
    Support 1 (S1) 1.14 1.13 1.19 1.17 1.02
    Support 2 (S2) 0.97 1.07 0.99 1.00
    Support 3 (S3) 0.88 0.97 0.98
    Support 4 (S4) 0.91